This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jun;8(6):305.

doi: 10.1038/nrcardio.2011.60. Epub 2011 Apr 5.

Antiplatelet therapy. The GRAVITAS of clopidogrel dose

PMID: 21468136
DOI: 10.1038/nrcardio.2011.60

Comment

Antiplatelet therapy. The GRAVITAS of clopidogrel dose

Joana Osório. Nat Rev Cardiol. 2011 Jun.

. 2011 Jun;8(6):305.

doi: 10.1038/nrcardio.2011.60. Epub 2011 Apr 5.

Author

PMID: 21468136
DOI: 10.1038/nrcardio.2011.60

No abstract available

PubMed Disclaimer

Comment on

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.
Price MJ, Berger PB, Teirstein PS, Tanguay JF, Angiolillo DJ, Spriggs D, Puri S, Robbins M, Garratt KN, Bertrand OF, Stillabower ME, Aragon JR, Kandzari DE, Stinis CT, Lee MS, Manoukian SV, Cannon CP, Schork NJ, Topol EJ; GRAVITAS Investigators. Price MJ, et al. JAMA. 2011 Mar 16;305(11):1097-105. doi: 10.1001/jama.2011.290. JAMA. 2011. PMID: 21406646 Clinical Trial.

References

1. JAMA. 2011 Mar 16;305(11):1097-105 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.